Methodological Challenges in Assessing the Impact of Comorbidities on Costs in Alzheimer’s Disease Clinical Trials

European Journal of Health Economics - Germany
doi 10.1007/s10198-014-0648-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Recruitment, Retention and Other Methodological Issues Related to Clinical Trials for Alzheimer’s Disease

Journal of Nutrition, Health and Aging
MedicineNutritionGerontologyGeriatricsDietetics
2012English

Challenges in Clinical Research on Alzheimer’s Disease: Leon Thal’s Legacy

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2007English

Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials

Neurotherapeutics
NeurologyPharmacology
2016English

Challenges Assessing Clinical Endpoints in Early Huntington Disease

Movement Disorders
Neurology
2010English

Clinical Trials on Sarcopenia: Methodological Issues Regarding Phase 3 Trials

Clinics in Geriatric Medicine
GerontologyGeriatrics
2011English

A Review of Drugs for Treatment of Alzheimer’s Disease in Clinical Trials: Main Trends

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2016English

Assessing Usual Care in Clinical Trials

Western Journal of Nursing Research
Nursing
2014English

Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease

Behavioural Neurology
MedicineNeurologyPhysiological PsychologyNeuropsychology
2009English

Physical Therapy in Patients With Alzheimer’s Disease: A Systematic Review of Randomized Controlled Clinical Trials

Fisioterapia e Pesquisa
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy